nodes	percent_of_prediction	percent_of_DWPC	metapath
Ibandronate—FDPS—Cholesterol Biosynthesis—HMGCR—atherosclerosis	0.0255	0.114	CbGpPWpGaD
Ibandronate—FDPS—Cholesterol biosynthesis—HMGCR—atherosclerosis	0.0188	0.0836	CbGpPWpGaD
Ibandronate—FDPS—Activation of gene expression by SREBF (SREBP)—HMGCR—atherosclerosis	0.0116	0.0518	CbGpPWpGaD
Ibandronate—FDPS—Regulation of cholesterol biosynthesis by SREBP (SREBF)—HMGCR—atherosclerosis	0.00929	0.0414	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—LDLR—atherosclerosis	0.00852	0.0379	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—SCARB1—atherosclerosis	0.00797	0.0355	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—HMGCR—atherosclerosis	0.00752	0.0335	CbGpPWpGaD
Ibandronate—FDPS—Activation of gene expression by SREBF (SREBP)—PPARA—atherosclerosis	0.00719	0.032	CbGpPWpGaD
Ibandronate—FDPS—Regulation of cholesterol biosynthesis by SREBP (SREBF)—PPARA—atherosclerosis	0.00574	0.0255	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—SIRT1—atherosclerosis	0.00559	0.0249	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—LPL—atherosclerosis	0.00526	0.0234	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	0.00411	0.0183	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	0.00386	0.0172	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—PPARG—atherosclerosis	0.00384	0.0171	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—INS—atherosclerosis	0.00377	0.0168	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	0.00335	0.0149	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	0.00335	0.0149	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.00265	0.0118	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	0.00249	0.0111	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	0.00249	0.0111	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	0.00244	0.0109	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	0.0024	0.0107	CbGpPWpGaD
Ibandronate—Weight decreased—Pravastatin—atherosclerosis	0.00239	0.00309	CcSEcCtD
Ibandronate—Depression—Pravastatin—atherosclerosis	0.00235	0.00303	CcSEcCtD
Ibandronate—Angioedema—Rosuvastatin—atherosclerosis	0.00234	0.00303	CcSEcCtD
Ibandronate—Stomatitis—Niacin—atherosclerosis	0.00233	0.00301	CcSEcCtD
Ibandronate—Sweating—Niacin—atherosclerosis	0.00229	0.00296	CcSEcCtD
Ibandronate—Urinary tract infection—Pravastatin—atherosclerosis	0.00229	0.00296	CcSEcCtD
Ibandronate—Chills—Lovastatin—atherosclerosis	0.00224	0.0029	CcSEcCtD
Ibandronate—Angiopathy—Ezetimibe—atherosclerosis	0.00222	0.00287	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	0.00222	0.00988	CbGpPWpGaD
Ibandronate—Immune system disorder—Ezetimibe—atherosclerosis	0.00221	0.00286	CcSEcCtD
Ibandronate—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00221	0.00285	CcSEcCtD
Ibandronate—Alopecia—Lovastatin—atherosclerosis	0.00221	0.00285	CcSEcCtD
Ibandronate—Myalgia—Rosuvastatin—atherosclerosis	0.00218	0.00282	CcSEcCtD
Ibandronate—Arthralgia—Rosuvastatin—atherosclerosis	0.00218	0.00282	CcSEcCtD
Ibandronate—Alopecia—Ezetimibe—atherosclerosis	0.00216	0.0028	CcSEcCtD
Ibandronate—Haemoglobin—Niacin—atherosclerosis	0.00216	0.00279	CcSEcCtD
Ibandronate—Mental disorder—Ezetimibe—atherosclerosis	0.00215	0.00277	CcSEcCtD
Ibandronate—Haemorrhage—Niacin—atherosclerosis	0.00214	0.00277	CcSEcCtD
Ibandronate—Flatulence—Lovastatin—atherosclerosis	0.00214	0.00277	CcSEcCtD
Ibandronate—Erythema—Ezetimibe—atherosclerosis	0.00213	0.00276	CcSEcCtD
Ibandronate—Malnutrition—Ezetimibe—atherosclerosis	0.00213	0.00276	CcSEcCtD
Ibandronate—Dysgeusia—Lovastatin—atherosclerosis	0.00213	0.00275	CcSEcCtD
Ibandronate—Oedema peripheral—Niacin—atherosclerosis	0.00211	0.00273	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	0.0021	0.00936	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	0.0021	0.00936	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	0.0021	0.00936	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	0.0021	0.00936	CbGpPWpGaD
Ibandronate—Back pain—Lovastatin—atherosclerosis	0.0021	0.00272	CcSEcCtD
Ibandronate—Flatulence—Ezetimibe—atherosclerosis	0.0021	0.00272	CcSEcCtD
Ibandronate—Pharyngitis—Pravastatin—atherosclerosis	0.0021	0.00271	CcSEcCtD
Ibandronate—Chills—Simvastatin—atherosclerosis	0.0021	0.00271	CcSEcCtD
Ibandronate—Muscle spasms—Lovastatin—atherosclerosis	0.00209	0.0027	CcSEcCtD
Ibandronate—Infection—Rosuvastatin—atherosclerosis	0.00208	0.00269	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	0.00208	0.00925	CbGpPWpGaD
Ibandronate—Alopecia—Simvastatin—atherosclerosis	0.00206	0.00267	CcSEcCtD
Ibandronate—Back pain—Ezetimibe—atherosclerosis	0.00206	0.00267	CcSEcCtD
Ibandronate—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00205	0.00265	CcSEcCtD
Ibandronate—Muscle spasms—Ezetimibe—atherosclerosis	0.00205	0.00265	CcSEcCtD
Ibandronate—Mental disorder—Simvastatin—atherosclerosis	0.00205	0.00265	CcSEcCtD
Ibandronate—Erythema—Simvastatin—atherosclerosis	0.00203	0.00263	CcSEcCtD
Ibandronate—Ill-defined disorder—Lovastatin—atherosclerosis	0.00202	0.00261	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	0.00201	0.00893	CbGpPWpGaD
Ibandronate—Eye disorder—Niacin—atherosclerosis	0.002	0.00259	CcSEcCtD
Ibandronate—Flatulence—Simvastatin—atherosclerosis	0.002	0.00259	CcSEcCtD
Ibandronate—Dysgeusia—Simvastatin—atherosclerosis	0.00199	0.00257	CcSEcCtD
Ibandronate—Risedronate—PTGS2—atherosclerosis	0.00199	1	CrCbGaD
Ibandronate—Angioedema—Lovastatin—atherosclerosis	0.00199	0.00257	CcSEcCtD
Ibandronate—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00198	0.00256	CcSEcCtD
Ibandronate—Anaemia—Ezetimibe—atherosclerosis	0.00197	0.00255	CcSEcCtD
Ibandronate—Malaise—Lovastatin—atherosclerosis	0.00196	0.00253	CcSEcCtD
Ibandronate—Cardiac disorder—Pravastatin—atherosclerosis	0.00196	0.00253	CcSEcCtD
Ibandronate—Muscle spasms—Simvastatin—atherosclerosis	0.00195	0.00253	CcSEcCtD
Ibandronate—Vertigo—Lovastatin—atherosclerosis	0.00195	0.00253	CcSEcCtD
Ibandronate—Angioedema—Ezetimibe—atherosclerosis	0.00195	0.00252	CcSEcCtD
Ibandronate—Angiopathy—Niacin—atherosclerosis	0.00195	0.00252	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	0.00192	0.00856	CbGpPWpGaD
Ibandronate—Chills—Niacin—atherosclerosis	0.00192	0.00249	CcSEcCtD
Ibandronate—Malaise—Ezetimibe—atherosclerosis	0.00192	0.00249	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00191	0.00247	CcSEcCtD
Ibandronate—Alopecia—Niacin—atherosclerosis	0.00189	0.00245	CcSEcCtD
Ibandronate—Chills—Pravastatin—atherosclerosis	0.00189	0.00245	CcSEcCtD
Ibandronate—Insomnia—Rosuvastatin—atherosclerosis	0.00189	0.00245	CcSEcCtD
Ibandronate—Ill-defined disorder—Simvastatin—atherosclerosis	0.00189	0.00244	CcSEcCtD
Ibandronate—Palpitations—Ezetimibe—atherosclerosis	0.00188	0.00244	CcSEcCtD
Ibandronate—Paraesthesia—Rosuvastatin—atherosclerosis	0.00188	0.00243	CcSEcCtD
Ibandronate—Anaemia—Simvastatin—atherosclerosis	0.00188	0.00243	CcSEcCtD
Ibandronate—Malnutrition—Niacin—atherosclerosis	0.00187	0.00241	CcSEcCtD
Ibandronate—Erythema—Niacin—atherosclerosis	0.00187	0.00241	CcSEcCtD
Ibandronate—Alopecia—Pravastatin—atherosclerosis	0.00187	0.00241	CcSEcCtD
Ibandronate—Angioedema—Simvastatin—atherosclerosis	0.00186	0.0024	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	0.00185	0.00824	CbGpPWpGaD
Ibandronate—Myalgia—Lovastatin—atherosclerosis	0.00185	0.00239	CcSEcCtD
Ibandronate—Chest pain—Lovastatin—atherosclerosis	0.00185	0.00239	CcSEcCtD
Ibandronate—Arthralgia—Lovastatin—atherosclerosis	0.00185	0.00239	CcSEcCtD
Ibandronate—Anxiety—Lovastatin—atherosclerosis	0.00184	0.00238	CcSEcCtD
Ibandronate—Dyspepsia—Rosuvastatin—atherosclerosis	0.00184	0.00238	CcSEcCtD
Ibandronate—Hypertension—Ezetimibe—atherosclerosis	0.00184	0.00238	CcSEcCtD
Ibandronate—Flatulence—Niacin—atherosclerosis	0.00184	0.00238	CcSEcCtD
Ibandronate—Malaise—Simvastatin—atherosclerosis	0.00183	0.00237	CcSEcCtD
Ibandronate—FDPS—Metabolism—LDLRAP1—atherosclerosis	0.00183	0.00815	CbGpPWpGaD
Ibandronate—Discomfort—Lovastatin—atherosclerosis	0.00183	0.00236	CcSEcCtD
Ibandronate—Vertigo—Simvastatin—atherosclerosis	0.00183	0.00236	CcSEcCtD
Ibandronate—Myalgia—Ezetimibe—atherosclerosis	0.00181	0.00235	CcSEcCtD
Ibandronate—Arthralgia—Ezetimibe—atherosclerosis	0.00181	0.00235	CcSEcCtD
Ibandronate—Chest pain—Ezetimibe—atherosclerosis	0.00181	0.00235	CcSEcCtD
Ibandronate—Flatulence—Pravastatin—atherosclerosis	0.00181	0.00234	CcSEcCtD
Ibandronate—Dry mouth—Lovastatin—atherosclerosis	0.00181	0.00234	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.0018	0.00233	CcSEcCtD
Ibandronate—Dysgeusia—Pravastatin—atherosclerosis	0.0018	0.00233	CcSEcCtD
Ibandronate—Muscle spasms—Niacin—atherosclerosis	0.00179	0.00232	CcSEcCtD
Ibandronate—Discomfort—Ezetimibe—atherosclerosis	0.00179	0.00232	CcSEcCtD
Ibandronate—Pain—Rosuvastatin—atherosclerosis	0.00179	0.00231	CcSEcCtD
Ibandronate—Constipation—Rosuvastatin—atherosclerosis	0.00179	0.00231	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	0.00179	0.00796	CbGpPWpGaD
Ibandronate—Dry mouth—Ezetimibe—atherosclerosis	0.00177	0.0023	CcSEcCtD
Ibandronate—Anaphylactic shock—Lovastatin—atherosclerosis	0.00177	0.00229	CcSEcCtD
Ibandronate—Muscle spasms—Pravastatin—atherosclerosis	0.00177	0.00229	CcSEcCtD
Ibandronate—Infection—Lovastatin—atherosclerosis	0.00176	0.00228	CcSEcCtD
Ibandronate—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00174	0.00225	CcSEcCtD
Ibandronate—Arthralgia—Simvastatin—atherosclerosis	0.00173	0.00224	CcSEcCtD
Ibandronate—Chest pain—Simvastatin—atherosclerosis	0.00173	0.00224	CcSEcCtD
Ibandronate—Myalgia—Simvastatin—atherosclerosis	0.00173	0.00224	CcSEcCtD
Ibandronate—Infection—Ezetimibe—atherosclerosis	0.00173	0.00224	CcSEcCtD
Ibandronate—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00172	0.00223	CcSEcCtD
Ibandronate—Anxiety—Simvastatin—atherosclerosis	0.00172	0.00223	CcSEcCtD
Ibandronate—FDPS—Metabolism—PLTP—atherosclerosis	0.00172	0.00766	CbGpPWpGaD
Ibandronate—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00171	0.00221	CcSEcCtD
Ibandronate—Discomfort—Simvastatin—atherosclerosis	0.00171	0.00221	CcSEcCtD
Ibandronate—Nervous system disorder—Ezetimibe—atherosclerosis	0.00171	0.00221	CcSEcCtD
Ibandronate—Angioedema—Niacin—atherosclerosis	0.00171	0.00221	CcSEcCtD
Ibandronate—Ill-defined disorder—Pravastatin—atherosclerosis	0.00171	0.00221	CcSEcCtD
Ibandronate—Anaemia—Pravastatin—atherosclerosis	0.0017	0.0022	CcSEcCtD
Ibandronate—Skin disorder—Ezetimibe—atherosclerosis	0.00169	0.00219	CcSEcCtD
Ibandronate—Angioedema—Pravastatin—atherosclerosis	0.00168	0.00217	CcSEcCtD
Ibandronate—Vertigo—Niacin—atherosclerosis	0.00168	0.00217	CcSEcCtD
Ibandronate—Urticaria—Rosuvastatin—atherosclerosis	0.00166	0.00215	CcSEcCtD
Ibandronate—Anaphylactic shock—Simvastatin—atherosclerosis	0.00166	0.00215	CcSEcCtD
Ibandronate—Malaise—Pravastatin—atherosclerosis	0.00166	0.00214	CcSEcCtD
Ibandronate—Abdominal pain—Rosuvastatin—atherosclerosis	0.00165	0.00214	CcSEcCtD
Ibandronate—Vertigo—Pravastatin—atherosclerosis	0.00165	0.00214	CcSEcCtD
Ibandronate—Palpitations—Niacin—atherosclerosis	0.00165	0.00213	CcSEcCtD
Ibandronate—Infection—Simvastatin—atherosclerosis	0.00165	0.00213	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00162	0.00209	CcSEcCtD
Ibandronate—Insomnia—Lovastatin—atherosclerosis	0.0016	0.00207	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	0.00159	0.0071	CbGpPWpGaD
Ibandronate—Paraesthesia—Lovastatin—atherosclerosis	0.00159	0.00206	CcSEcCtD
Ibandronate—Myalgia—Niacin—atherosclerosis	0.00159	0.00206	CcSEcCtD
Ibandronate—Arthralgia—Niacin—atherosclerosis	0.00159	0.00206	CcSEcCtD
Ibandronate—Hypertension—Pravastatin—atherosclerosis	0.00159	0.00205	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00159	0.00205	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	0.00158	0.00705	CbGpPWpGaD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00158	0.00204	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	0.00158	0.00701	CbGpPWpGaD
Ibandronate—Insomnia—Ezetimibe—atherosclerosis	0.00157	0.00203	CcSEcCtD
Ibandronate—Chest pain—Pravastatin—atherosclerosis	0.00156	0.00202	CcSEcCtD
Ibandronate—Arthralgia—Pravastatin—atherosclerosis	0.00156	0.00202	CcSEcCtD
Ibandronate—Myalgia—Pravastatin—atherosclerosis	0.00156	0.00202	CcSEcCtD
Ibandronate—Paraesthesia—Ezetimibe—atherosclerosis	0.00156	0.00202	CcSEcCtD
Ibandronate—Dyspepsia—Lovastatin—atherosclerosis	0.00156	0.00202	CcSEcCtD
Ibandronate—Anxiety—Pravastatin—atherosclerosis	0.00156	0.00202	CcSEcCtD
Ibandronate—Dry mouth—Niacin—atherosclerosis	0.00155	0.00201	CcSEcCtD
Ibandronate—Discomfort—Pravastatin—atherosclerosis	0.00155	0.002	CcSEcCtD
Ibandronate—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00154	0.00199	CcSEcCtD
Ibandronate—Decreased appetite—Lovastatin—atherosclerosis	0.00154	0.00199	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	0.00154	0.00685	CbGpPWpGaD
Ibandronate—Dyspepsia—Ezetimibe—atherosclerosis	0.00153	0.00198	CcSEcCtD
Ibandronate—Fatigue—Lovastatin—atherosclerosis	0.00153	0.00198	CcSEcCtD
Ibandronate—Anaphylactic shock—Niacin—atherosclerosis	0.00152	0.00197	CcSEcCtD
Ibandronate—FDPS—SREBP signalling—AKT1—atherosclerosis	0.00152	0.00676	CbGpPWpGaD
Ibandronate—Pain—Lovastatin—atherosclerosis	0.00152	0.00196	CcSEcCtD
Ibandronate—Constipation—Lovastatin—atherosclerosis	0.00152	0.00196	CcSEcCtD
Ibandronate—Decreased appetite—Ezetimibe—atherosclerosis	0.00151	0.00196	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00151	0.00195	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.0015	0.00194	CcSEcCtD
Ibandronate—Asthenia—Rosuvastatin—atherosclerosis	0.0015	0.00194	CcSEcCtD
Ibandronate—Insomnia—Simvastatin—atherosclerosis	0.0015	0.00194	CcSEcCtD
Ibandronate—Anaphylactic shock—Pravastatin—atherosclerosis	0.0015	0.00194	CcSEcCtD
Ibandronate—Fatigue—Ezetimibe—atherosclerosis	0.0015	0.00194	CcSEcCtD
Ibandronate—Shock—Niacin—atherosclerosis	0.0015	0.00194	CcSEcCtD
Ibandronate—FDPS—Metabolism—ABCG8—atherosclerosis	0.00149	0.00664	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—LTA4H—atherosclerosis	0.00149	0.00664	CbGpPWpGaD
Ibandronate—Infection—Pravastatin—atherosclerosis	0.00149	0.00193	CcSEcCtD
Ibandronate—Paraesthesia—Simvastatin—atherosclerosis	0.00149	0.00193	CcSEcCtD
Ibandronate—Pain—Ezetimibe—atherosclerosis	0.00149	0.00192	CcSEcCtD
Ibandronate—Constipation—Ezetimibe—atherosclerosis	0.00149	0.00192	CcSEcCtD
Ibandronate—Pruritus—Rosuvastatin—atherosclerosis	0.00148	0.00191	CcSEcCtD
Ibandronate—Skin disorder—Niacin—atherosclerosis	0.00148	0.00191	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	0.00147	0.00656	CbGpPWpGaD
Ibandronate—Hyperhidrosis—Niacin—atherosclerosis	0.00147	0.0019	CcSEcCtD
Ibandronate—Feeling abnormal—Lovastatin—atherosclerosis	0.00146	0.00189	CcSEcCtD
Ibandronate—Dyspepsia—Simvastatin—atherosclerosis	0.00146	0.00189	CcSEcCtD
Ibandronate—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00145	0.00188	CcSEcCtD
Ibandronate—Hyperhidrosis—Pravastatin—atherosclerosis	0.00145	0.00188	CcSEcCtD
Ibandronate—Decreased appetite—Simvastatin—atherosclerosis	0.00144	0.00187	CcSEcCtD
Ibandronate—Feeling abnormal—Ezetimibe—atherosclerosis	0.00143	0.00185	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00143	0.00185	CcSEcCtD
Ibandronate—Diarrhoea—Rosuvastatin—atherosclerosis	0.00143	0.00185	CcSEcCtD
Ibandronate—Fatigue—Simvastatin—atherosclerosis	0.00143	0.00185	CcSEcCtD
Ibandronate—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00142	0.00184	CcSEcCtD
Ibandronate—Pain—Simvastatin—atherosclerosis	0.00142	0.00183	CcSEcCtD
Ibandronate—Constipation—Simvastatin—atherosclerosis	0.00142	0.00183	CcSEcCtD
Ibandronate—Urticaria—Lovastatin—atherosclerosis	0.00141	0.00182	CcSEcCtD
Ibandronate—Body temperature increased—Lovastatin—atherosclerosis	0.0014	0.00181	CcSEcCtD
Ibandronate—Abdominal pain—Lovastatin—atherosclerosis	0.0014	0.00181	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	0.00139	0.00619	CbGpPWpGaD
Ibandronate—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00139	0.00179	CcSEcCtD
Ibandronate—Dizziness—Rosuvastatin—atherosclerosis	0.00138	0.00179	CcSEcCtD
Ibandronate—Urticaria—Ezetimibe—atherosclerosis	0.00138	0.00179	CcSEcCtD
Ibandronate—Insomnia—Niacin—atherosclerosis	0.00138	0.00178	CcSEcCtD
Ibandronate—Abdominal pain—Ezetimibe—atherosclerosis	0.00138	0.00178	CcSEcCtD
Ibandronate—Body temperature increased—Ezetimibe—atherosclerosis	0.00138	0.00178	CcSEcCtD
Ibandronate—Paraesthesia—Niacin—atherosclerosis	0.00137	0.00177	CcSEcCtD
Ibandronate—Feeling abnormal—Simvastatin—atherosclerosis	0.00137	0.00177	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00137	0.00177	CcSEcCtD
Ibandronate—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00136	0.00175	CcSEcCtD
Ibandronate—Insomnia—Pravastatin—atherosclerosis	0.00136	0.00175	CcSEcCtD
Ibandronate—Paraesthesia—Pravastatin—atherosclerosis	0.00135	0.00174	CcSEcCtD
Ibandronate—Dyspepsia—Niacin—atherosclerosis	0.00134	0.00173	CcSEcCtD
Ibandronate—Decreased appetite—Niacin—atherosclerosis	0.00132	0.00171	CcSEcCtD
Ibandronate—Dyspepsia—Pravastatin—atherosclerosis	0.00132	0.00171	CcSEcCtD
Ibandronate—Rash—Rosuvastatin—atherosclerosis	0.00132	0.00171	CcSEcCtD
Ibandronate—Dermatitis—Rosuvastatin—atherosclerosis	0.00132	0.00171	CcSEcCtD
Ibandronate—Urticaria—Simvastatin—atherosclerosis	0.00132	0.0017	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Niacin—atherosclerosis	0.00132	0.0017	CcSEcCtD
Ibandronate—Body temperature increased—Simvastatin—atherosclerosis	0.00131	0.0017	CcSEcCtD
Ibandronate—Abdominal pain—Simvastatin—atherosclerosis	0.00131	0.0017	CcSEcCtD
Ibandronate—Headache—Rosuvastatin—atherosclerosis	0.00131	0.0017	CcSEcCtD
Ibandronate—Hypersensitivity—Lovastatin—atherosclerosis	0.00131	0.00169	CcSEcCtD
Ibandronate—Decreased appetite—Pravastatin—atherosclerosis	0.0013	0.00169	CcSEcCtD
Ibandronate—Pain—Niacin—atherosclerosis	0.0013	0.00168	CcSEcCtD
Ibandronate—Fatigue—Pravastatin—atherosclerosis	0.00129	0.00167	CcSEcCtD
Ibandronate—Constipation—Pravastatin—atherosclerosis	0.00128	0.00166	CcSEcCtD
Ibandronate—Pain—Pravastatin—atherosclerosis	0.00128	0.00166	CcSEcCtD
Ibandronate—Hypersensitivity—Ezetimibe—atherosclerosis	0.00128	0.00166	CcSEcCtD
Ibandronate—Asthenia—Lovastatin—atherosclerosis	0.00127	0.00165	CcSEcCtD
Ibandronate—Pruritus—Lovastatin—atherosclerosis	0.00125	0.00162	CcSEcCtD
Ibandronate—Asthenia—Ezetimibe—atherosclerosis	0.00125	0.00161	CcSEcCtD
Ibandronate—Gastrointestinal pain—Niacin—atherosclerosis	0.00125	0.00161	CcSEcCtD
Ibandronate—Nausea—Rosuvastatin—atherosclerosis	0.00124	0.00161	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	0.00124	0.00552	CbGpPWpGaD
Ibandronate—Feeling abnormal—Pravastatin—atherosclerosis	0.00124	0.0016	CcSEcCtD
Ibandronate—Pruritus—Ezetimibe—atherosclerosis	0.00123	0.00159	CcSEcCtD
Ibandronate—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00123	0.00159	CcSEcCtD
Ibandronate—Hypersensitivity—Simvastatin—atherosclerosis	0.00122	0.00158	CcSEcCtD
Ibandronate—Diarrhoea—Lovastatin—atherosclerosis	0.00121	0.00157	CcSEcCtD
Ibandronate—Urticaria—Niacin—atherosclerosis	0.00121	0.00157	CcSEcCtD
Ibandronate—Body temperature increased—Niacin—atherosclerosis	0.0012	0.00156	CcSEcCtD
Ibandronate—Abdominal pain—Niacin—atherosclerosis	0.0012	0.00156	CcSEcCtD
Ibandronate—Urticaria—Pravastatin—atherosclerosis	0.00119	0.00154	CcSEcCtD
Ibandronate—Asthenia—Simvastatin—atherosclerosis	0.00119	0.00154	CcSEcCtD
Ibandronate—Diarrhoea—Ezetimibe—atherosclerosis	0.00119	0.00154	CcSEcCtD
Ibandronate—Abdominal pain—Pravastatin—atherosclerosis	0.00119	0.00153	CcSEcCtD
Ibandronate—Body temperature increased—Pravastatin—atherosclerosis	0.00119	0.00153	CcSEcCtD
Ibandronate—FDPS—Metabolism—ABCG1—atherosclerosis	0.00118	0.00525	CbGpPWpGaD
Ibandronate—Pruritus—Simvastatin—atherosclerosis	0.00117	0.00152	CcSEcCtD
Ibandronate—Dizziness—Lovastatin—atherosclerosis	0.00117	0.00152	CcSEcCtD
Ibandronate—Dizziness—Ezetimibe—atherosclerosis	0.00115	0.00149	CcSEcCtD
Ibandronate—Diarrhoea—Simvastatin—atherosclerosis	0.00114	0.00147	CcSEcCtD
Ibandronate—Vomiting—Lovastatin—atherosclerosis	0.00113	0.00146	CcSEcCtD
Ibandronate—Hypersensitivity—Niacin—atherosclerosis	0.00112	0.00145	CcSEcCtD
Ibandronate—Rash—Lovastatin—atherosclerosis	0.00112	0.00145	CcSEcCtD
Ibandronate—Dermatitis—Lovastatin—atherosclerosis	0.00112	0.00144	CcSEcCtD
Ibandronate—Headache—Lovastatin—atherosclerosis	0.00111	0.00144	CcSEcCtD
Ibandronate—FDPS—Metabolism—FABP4—atherosclerosis	0.00111	0.00494	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—LCAT—atherosclerosis	0.00111	0.00494	CbGpPWpGaD
Ibandronate—Vomiting—Ezetimibe—atherosclerosis	0.00111	0.00143	CcSEcCtD
Ibandronate—Hypersensitivity—Pravastatin—atherosclerosis	0.00111	0.00143	CcSEcCtD
Ibandronate—Dizziness—Simvastatin—atherosclerosis	0.0011	0.00142	CcSEcCtD
Ibandronate—Rash—Ezetimibe—atherosclerosis	0.0011	0.00142	CcSEcCtD
Ibandronate—Dermatitis—Ezetimibe—atherosclerosis	0.0011	0.00142	CcSEcCtD
Ibandronate—Asthenia—Niacin—atherosclerosis	0.00109	0.00141	CcSEcCtD
Ibandronate—Headache—Ezetimibe—atherosclerosis	0.00109	0.00141	CcSEcCtD
Ibandronate—FDPS—Metabolism—APOA4—atherosclerosis	0.00109	0.00484	CbGpPWpGaD
Ibandronate—Pruritus—Niacin—atherosclerosis	0.00108	0.00139	CcSEcCtD
Ibandronate—Asthenia—Pravastatin—atherosclerosis	0.00108	0.00139	CcSEcCtD
Ibandronate—FDPS—Metabolism—CYP7A1—atherosclerosis	0.00107	0.00476	CbGpPWpGaD
Ibandronate—Pruritus—Pravastatin—atherosclerosis	0.00106	0.00137	CcSEcCtD
Ibandronate—Vomiting—Simvastatin—atherosclerosis	0.00105	0.00136	CcSEcCtD
Ibandronate—Nausea—Lovastatin—atherosclerosis	0.00105	0.00136	CcSEcCtD
Ibandronate—Rash—Simvastatin—atherosclerosis	0.00105	0.00135	CcSEcCtD
Ibandronate—Dermatitis—Simvastatin—atherosclerosis	0.00105	0.00135	CcSEcCtD
Ibandronate—Diarrhoea—Niacin—atherosclerosis	0.00104	0.00135	CcSEcCtD
Ibandronate—Headache—Simvastatin—atherosclerosis	0.00104	0.00134	CcSEcCtD
Ibandronate—Nausea—Ezetimibe—atherosclerosis	0.00103	0.00134	CcSEcCtD
Ibandronate—Diarrhoea—Pravastatin—atherosclerosis	0.00103	0.00133	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	0.00102	0.00454	CbGpPWpGaD
Ibandronate—Dizziness—Niacin—atherosclerosis	0.00101	0.0013	CcSEcCtD
Ibandronate—Dizziness—Pravastatin—atherosclerosis	0.000992	0.00128	CcSEcCtD
Ibandronate—FDPS—Metabolism—CYP27A1—atherosclerosis	0.000989	0.0044	CbGpPWpGaD
Ibandronate—Nausea—Simvastatin—atherosclerosis	0.000986	0.00127	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	0.000973	0.00433	CbGpPWpGaD
Ibandronate—Vomiting—Niacin—atherosclerosis	0.000969	0.00125	CcSEcCtD
Ibandronate—Rash—Niacin—atherosclerosis	0.000961	0.00124	CcSEcCtD
Ibandronate—Dermatitis—Niacin—atherosclerosis	0.00096	0.00124	CcSEcCtD
Ibandronate—Headache—Niacin—atherosclerosis	0.000954	0.00123	CcSEcCtD
Ibandronate—Vomiting—Pravastatin—atherosclerosis	0.000954	0.00123	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	0.000949	0.00423	CbGpPWpGaD
Ibandronate—Rash—Pravastatin—atherosclerosis	0.000946	0.00122	CcSEcCtD
Ibandronate—Dermatitis—Pravastatin—atherosclerosis	0.000945	0.00122	CcSEcCtD
Ibandronate—Headache—Pravastatin—atherosclerosis	0.00094	0.00122	CcSEcCtD
Ibandronate—FDPS—Metabolism—PLA2G2A—atherosclerosis	0.000937	0.00417	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—APOA2—atherosclerosis	0.000937	0.00417	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—ALOX15—atherosclerosis	0.000937	0.00417	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—ALOX5AP—atherosclerosis	0.000937	0.00417	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—ABCG5—atherosclerosis	0.000926	0.00412	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	0.000925	0.00411	CbGpPWpGaD
Ibandronate—Nausea—Niacin—atherosclerosis	0.000905	0.00117	CcSEcCtD
Ibandronate—FDPS—Metabolism—LPA—atherosclerosis	0.000894	0.00398	CbGpPWpGaD
Ibandronate—Nausea—Pravastatin—atherosclerosis	0.000891	0.00115	CcSEcCtD
Ibandronate—FDPS—Metabolism—BGN—atherosclerosis	0.000866	0.00385	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	0.00086	0.00383	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—APOA5—atherosclerosis	0.000857	0.00381	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	0.000833	0.0037	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PLA2G1B—atherosclerosis	0.000825	0.00367	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	0.000816	0.00363	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	0.000808	0.0036	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	0.000806	0.00359	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—ALOX5—atherosclerosis	0.000797	0.00355	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	0.000736	0.00328	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—NAMPT—atherosclerosis	0.000715	0.00318	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	0.000711	0.00316	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—LIPC—atherosclerosis	0.00071	0.00316	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—APOC3—atherosclerosis	0.000706	0.00314	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—LDLR—atherosclerosis	0.000701	0.00312	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CETP—atherosclerosis	0.000685	0.00305	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—SCARB1—atherosclerosis	0.000656	0.00292	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	0.000639	0.00284	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—HMGCR—atherosclerosis	0.00062	0.00276	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	0.000559	0.00249	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—ABCA1—atherosclerosis	0.000552	0.00246	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—HMOX1—atherosclerosis	0.000474	0.00211	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—APOB—atherosclerosis	0.000454	0.00202	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—GSTM1—atherosclerosis	0.000442	0.00196	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—LPL—atherosclerosis	0.000433	0.00193	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—GPX1—atherosclerosis	0.000423	0.00188	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CD36—atherosclerosis	0.000412	0.00183	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—MTHFR—atherosclerosis	0.00039	0.00174	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PPARA—atherosclerosis	0.000383	0.0017	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—AGT—atherosclerosis	0.000371	0.00165	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—APOE—atherosclerosis	0.000363	0.00162	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CAV1—atherosclerosis	0.00036	0.0016	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—APOA1—atherosclerosis	0.000359	0.0016	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PIK3CG—atherosclerosis	0.000328	0.00146	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PPARG—atherosclerosis	0.000316	0.00141	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—INS—atherosclerosis	0.00031	0.00138	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—ALB—atherosclerosis	0.000285	0.00127	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—NOS3—atherosclerosis	0.000272	0.00121	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PTGS2—atherosclerosis	0.000249	0.00111	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—AKT1—atherosclerosis	0.000125	0.000557	CbGpPWpGaD
